What Documents Must Be Prepared Before Singapore HSA Medical Device Registration?

What Documents Must Be Prepared Before Singapore HSA Medical Device Registration?

Direct answer: Before registering a medical device with Singapore's Health Sciences Authority (HSA), the manufacturer should not simply assemble documents against a checklist. Four tasks must be completed first: confirm whether the product is a medical device and determine its risk class; determine the applicable registration route and whether reliance on reference regulatory agency approvals is available; appoint the Singapore local registrant and settle certificate control arrangements; and only then build a dossier centred on the technical file, quality management system, clinical or performance evidence, labelling and instructions for use, and post-market obligations. HSA focuses on product safety, performance, intended use and the consistency of the submitted information, so a gap assessment should be completed before submission to identify which documents can be reused and which require additional testing, translation, localisation or re-justification.

Source and reference basis

Prepared with reference to publicly available official information from Singapore's Health Sciences Authority (HSA), combined with experience from AIMEILI medical device international registration projects.

• Official source: Singapore Health Sciences Authority (HSA)
• Source link: https://www.hsa.gov.sg/medical-devices/registration-of-medical-devices/register-your-device/

HSA's registration page states that, after determining the evaluation route and risk class, companies should use the corresponding registration guidance to confirm the required documents, fees and processing times. HSA's guidance document directory also covers registration, changes, dealer licences, special access routes, advertising and sales, and post-market safety monitoring.

Published: 08 July 2026, 09:00　|　Updated: 08 July 2026, 09:00

Who should read this

This article is intended for medical device manufacturers, IVD companies, software-as-a-medical-device companies, regulatory affairs professionals and international business leads preparing to enter the Singapore market. It is particularly relevant for companies that already hold approvals in China, the EU, the United States, Australia or other markets but are unsure whether those materials can be reused for a Singapore registration.

Step 1: Determine the product's risk class and registration route first

Singapore's medical device regulation is generally risk-based. Companies should first determine whether the product qualifies as a medical device, whether it is an IVD, whether it involves software functionality, whether it is a combination product, and whether its intended purpose and mode of action raise its risk class. The risk class directly affects the depth of documentation required, the review route, timelines and fees.

Where reference regulatory agency approvals already exist, the company must still assess whether they can support an abbreviated or shortened review. It should not be assumed that holding a CE mark or FDA clearance automatically makes Singapore registration straightforward.

Step 2: Confirm the local registrant and certificate control arrangements

An overseas manufacturer generally needs a Singapore-based compliant entity to support submission and ongoing maintenance. This role affects not only submission efficiency but also certificate control, change notifications, post-market regulatory responses and distributor replacement.

Before registration, contracts should clearly define the registrant's responsibilities, certificate ownership, the term of authorisation, handover of documents, cooperation on changes, and termination mechanisms, so that changes in distribution relationships do not later affect use of the certificate.

Step 3: Build a dossier, not a pile of documents

A reasonably complete Singapore registration dossier typically includes the device description, model and specification variants, intended use, justification for the risk classification, evidence of the quality management system, the technical file, performance verification, clinical or evaluation evidence, risk management, labelling and instructions for use, a declaration of conformity, approvals from reference markets, manufacturer authorisation and local registrant information.

IVDs, software, connected devices, sterile products, implantables and active devices require additional attention to specific evidence, such as performance evaluation, the software lifecycle, cybersecurity, sterilisation validation, electrical safety or biocompatibility.

Common mistakes

• Submitting domestic registration documents after translation only, without restructuring them for HSA requirements.
• Failing to re-assess the device classification under Singapore's own rules.
• Inconsistency between model and specification ranges, labelling, instructions for use and test reports.
• Overlooking the responsibilities of the Singapore local registrant.
• Preparing only initial registration documents, without designing processes for changes, certificate renewal, complaints and recalls.

For HSA projects, consistency between documents is often more important than the sheer number of documents submitted.

AIMEILI recommendations

AIMEILI recommends that companies treat Singapore as a high-quality benchmark market for ASEAN. At project initiation, carry out three assessments: registration route, documentation gaps, and the local responsible entity. Then arrange translation, authorisation and submission.

For companies planning to expand into Thailand, Malaysia, Indonesia, Vietnam and other markets, the Singapore dossier can also serve as an important foundation for an ASEAN documentation system, but country-specific localisation differences must be retained.

Internal checklist

• Is the product a medical device, and what is its specific risk class?
• Are there reference regulatory agency approvals available to support route determination?
• Is the local registrant clearly identified, and is certificate control written into the contract?
• Are the technical file, labelling, instructions for use, test reports and model specifications consistent?
• Are additional performance, clinical, software, cybersecurity or sterilisation documents required?
• Are post-market change, complaint, adverse event and recall responsibilities in place?

Further reading

• Previous: How do the EU EUDAMED and SSCP management requirements affect MDR certificate holders?
• Next: Which compliance obligations must be confirmed before Australian TGA medical device registration?
• Recommended: What should companies prepare following the update to Health Canada's medical device regulatory registration process?
• Recommended: Which submission strategies are affected by the updated Singapore HSA medical device grouping registration guidance?
• Recommended: Which compliance obligations must be confirmed before Australian TGA medical device registration?
• Recommended: What must be prepared before Australian TGA medical device registration?
• Recommended: Can CE documentation be reused for Singapore HSA medical device registration?
• Recommended: Which core documents are required for UAE MOHAP medical device registration?

Return to the FAQ centre for news and updates, or contact AIMEILI.

Content review and scope

• Author: AIMEILI Regulatory Editorial Team
• Professional review: AIMEILI Medical Device International Registration Project Team
• Sourcing principle: Official regulatory agencies, international organisations, standards bodies and public regulatory materials are prioritised; industry media and project experience are used only as supplementary references.
• Scope: This article supports preliminary understanding, document preparation and project planning. It does not replace the formal requirements of the target country's regulatory authority, testing conclusions or legal advice.